VAERS reports by lot

Moderna COVID-19 lot 040821A: VAERS reports

35 VAERS reports list lot 040821A as a Moderna COVID-19 vaccine, received between 2021-03-12 and 2022-01-18. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
35
Reports
9%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5032%
Neurological3120%
Injection-site / Local reaction1510%
Musculoskeletal149%
Gastrointestinal138%
Respiratory85%
Dermatological (non-injection-site)85%
Cardiac / Cardiovascular75%
Allergic / Anaphylactic43%
Psychiatric / Neuropsychiatric43%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Indiana7
Pennsylvania5
New York4
New Jersey3
Virginia3
Michigan3
Vermont2
Washington1
Wisconsin1
Kentucky1
Connecticut1
Arkansas1

Reports by month received

2021-031
2021-0412
2021-052
2021-061
2021-071
2021-0813
2021-091
2021-122
2022-012

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.